| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/16/1999 | US5871731 Oral administration of immunoglobulin preparations for treatment of chronic pain syndrome |
| 02/16/1999 | US5871728 Enhancing tolerogenicity in host mammal to transplant graft specimen from donor; propagation in cytokine prior to administering |
| 02/16/1999 | US5871727 Targeted adenovirus vectors |
| 02/16/1999 | CA2122112C Adrenomedullin |
| 02/16/1999 | CA2000913C Family of high affinity antibodies for cancer treatment |
| 02/16/1999 | CA1340397C Method of preparation and use for zona pellucida antigens and antibodies for sterilization and contraception |
| 02/16/1999 | CA1340391C Monoclonal antibodies against atrial, natriuretic peptides of humans |
| 02/15/1999 | CA2224096A1 The g-protein coupled receptor hfia041 |
| 02/14/1999 | CA2239264A1 Novel uses |
| 02/13/1999 | CA2240637A1 Novel ratb |
| 02/13/1999 | CA2240627A1 Novel ratc |
| 02/13/1999 | CA2240623A1 Novel rata |
| 02/12/1999 | CA2239837A1 Novel murd |
| 02/12/1999 | CA2239835A1 Human sdr2 cdna clone |
| 02/12/1999 | CA2239819A1 Ftsz |
| 02/12/1999 | CA2231728A1 Mray |
| 02/11/1999 | WO1999006562A1 Method enabling readministration of aav vector via immunosuppression of host |
| 02/11/1999 | WO1999006561A2 Chemokine receptor ccr8 dna and uses thereof |
| 02/11/1999 | WO1999006558A1 Human longevity-assurance protein homologs |
| 02/11/1999 | WO1999006557A2 Mammalian cell membrane proteins; related reagents |
| 02/11/1999 | WO1999006544A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 02/11/1999 | WO1999006428A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
| 02/11/1999 | WO1999006427A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
| 02/11/1999 | WO1999006423A1 83 human secreted proteins |
| 02/11/1999 | WO1999006069A1 Herpes virus replication defective mutants |
| 02/11/1999 | WO1999006068A2 Recombinant dimeric envelope vaccine against flaviviral infection |
| 02/11/1999 | WO1999006067A1 Method of removing endotoxin from vaccines |
| 02/11/1999 | WO1999006066A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 02/11/1999 | WO1999006061A1 Prediction, detection, and design of t cell epitopes |
| 02/11/1999 | WO1998050556A3 Intracellular production of hepatitis c e1 and e2 truncated polypeptides |
| 02/11/1999 | WO1998044948A3 Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties |
| 02/11/1999 | WO1998033528A3 Induction of b cell tolerance |
| 02/11/1999 | WO1998030239A3 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure |
| 02/11/1999 | DE19729591A1 Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen Agents for the treatment and / or prophylaxis of microcirculation disorders |
| 02/11/1999 | CA2299276A1 Tango-78, tango-79, and tango-81 nucleic acid molecules and polypeptides |
| 02/11/1999 | CA2299256A1 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
| 02/11/1999 | CA2298852A1 83 human secreted proteins |
| 02/11/1999 | CA2298766A1 Human longevity-assurance protein homologs |
| 02/11/1999 | CA2298538A1 Recombinant dimeric envelope vaccine against flaviviral infection |
| 02/11/1999 | CA2297747A1 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 02/11/1999 | CA2297490A1 Method enabling readministration of aav vector via immunosuppression of host |
| 02/11/1999 | CA2239836A1 Novel arginine deiminase |
| 02/11/1999 | CA2239813A1 Novel nrdd |
| 02/11/1999 | CA2239221A1 Novel his5 |
| 02/10/1999 | EP0896061A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0896060A2 RpoA gene from Staphylococcus aureus |
| 02/10/1999 | EP0896055A2 Apoptosis inducing protein and gene encoding the same |
| 02/10/1999 | EP0895543A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 02/10/1999 | EP0895541A1 Non antibiotic selectable markers for live vaccines |
| 02/10/1999 | EP0895538A1 Mutated ras peptides for generation of cd8?+ cytotoxic t lymphocytes |
| 02/10/1999 | EP0895537A1 Iga1 protease fragment as carrier peptide |
| 02/10/1999 | EP0895535A1 Influenza virus replicated in mammalian cell culture and vaccine production |
| 02/10/1999 | EP0693120B1 Tumoricide t lymphocytes |
| 02/10/1999 | EP0597843B1 16 kDa SURFACE PROTEIN OF P. FALCIPARUM |
| 02/10/1999 | CN1207811A Method of diagnosing and treating epithelioma |
| 02/10/1999 | CN1207686A FC 'epsilon'-PE chimeric protein for targeted treatment of allergy responses, method for its production and pharmaceutical compositions contg. same |
| 02/10/1999 | CN1207395A Anti-FAS antibodies |
| 02/09/1999 | US5869638 Bone-related cadherin-like protein and process for its production |
| 02/09/1999 | US5869636 Recombinant cell line expressing polypetide for anticarcinogenic and antitumor agents and vaccines |
| 02/09/1999 | US5869633 Thrombin receptor homolog polynucleotide |
| 02/09/1999 | US5869631 A newly isolated human immunodeficiency virus capable of causing aids; having genetic polymorphism with variablility in the envelope region and glycosylation; detection and diagnosis of aids |
| 02/09/1999 | US5869624 HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof |
| 02/09/1999 | US5869619 Modified antibody variable domains |
| 02/09/1999 | US5869608 Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis |
| 02/09/1999 | US5869603 Amino acid sequences of synthetic peptides binding to neutralizing antibodies against recombinant interferon-beta; for detection and inhibition of antibodies in patients |
| 02/09/1999 | US5869534 Administering aminoguanidine and analogs thereof to reduce lipid oxidation and inhibit an increase in serum low density lipoproteins to prevent disease states characterized by the presence of advanced glycosylation endproducts |
| 02/09/1999 | US5869453 Cytotoxic T-cell epitopes |
| 02/09/1999 | US5869445 Methods for eliciting or enhancing reactivity to HER-2/neu protein |
| 02/09/1999 | US5869335 Propagating bovine parasite by incubation of undifferentiated cells under low oxygen increased carbon dioxide, with organic buffers; efficient, large scale production; diagnosis/vaccine for rocky mountains spotted fever |
| 02/09/1999 | US5869333 Ryegrass pollen allergen |
| 02/09/1999 | US5869313 Dna fragments coding for envelope and regulatory proteins of hiv-1 strains common to united states; for vaccines and detection in blood samples |
| 02/09/1999 | US5869312 Recombinant swinepox virus |
| 02/09/1999 | US5869308 Detection method for C-RAF-1 genes |
| 02/09/1999 | US5869306 Gene transfer preparation |
| 02/09/1999 | US5869302 Analog of haemophilus hin47 with reduced protease activity |
| 02/09/1999 | US5869290 Cayae1 polynucleotides |
| 02/09/1999 | US5869282 Nucleotide and protein sequences of the serrate gene and methods based thereon |
| 02/09/1999 | US5869281 For culturing and screening for modulators of receptor; glucoma, synchronization of animal estrus cycles, antitumor and antiprolferative agents |
| 02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/09/1999 | US5869270 Single chain MHC complexes and uses thereof |
| 02/09/1999 | US5869265 Screening modulators by contacting recombinant cells which express cotransporter with substance, determining increase or decrease in activity; anticholesterol agents; antidiabetic agents; liver disease; crohn's disease |
| 02/09/1999 | US5869262 Quantitative immunoassay by contacting serum from patient with antibodies against circulating intercellular adhesion molecule-r, detecting binding; higher levels indicate progression of systematic lupus erythematosus |
| 02/09/1999 | US5869253 Enzymatic ribozyme molecule having a substrate binding site and an active site that cleaves hepatitis c virus rna; diagnosis and viricides |
| 02/09/1999 | US5869093 Treatment of immune diseases by oral administration of autoantigens |
| 02/09/1999 | US5869077 Subcutaneously implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete insulin dispersed in biocompatible matrix, surrounded by biocompatible external permselective jacket |
| 02/09/1999 | US5869065 Haemophilus influenzae; otitis media; sinusitis; bronchitis; dna sequences; amino acid sequences |
| 02/09/1999 | US5869064 Protein rib, a cell surface protein that confers immunity to many strains of the group B Streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
| 02/09/1999 | US5869062 Skin treatment composition |
| 02/09/1999 | US5869058 Genetic engineering; complexing antigen with synthetic peptide carrier |
| 02/09/1999 | US5869057 Administering a fusion protein comprising pentamers of escherichia coli labile toxin subunit b and human chorionic gonadotropin |
| 02/09/1999 | US5869055 Anti-inflammatory CD14 polypeptides |
| 02/09/1999 | US5869054 Treatment of multiple sclerosis by oral administration of autoantigens |
| 02/09/1999 | US5869053 5T4 antigen from human trophoblasts |
| 02/09/1999 | US5869050 Administering to patient antibody against b7 antigen and immunosuppressive agent in synergistic mixture; treatment of transplant rejection, graft versus host disease, rheumatoid arthritis |
| 02/09/1999 | US5869047 Methods for therapeutically treating immunocomprised persons |
| 02/09/1999 | US5869036 Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine |
| 02/08/1999 | CA2239223A1 Novel rpoa |
| 02/08/1999 | CA2239222A1 Novel rpoa |
| 02/06/1999 | CA2239256A1 Novel lgt |
| 02/05/1999 | CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses |